Charcot-Marie-Tooth disease type 1A (CMT1A) is an autosomal dominant n
europathy that can be caused by dominant point mutations in PMP22 whic
h encodes a peripheral nerve myelin protein. Usually, CMT1A is caused
by the duplication of a 1.5-megabase (Mb) region on chromosome 17p11.2
-p12 containing PMP22. Deletion of a similar 1.5-Mb region is associat
ed with hereditary neuropathy with liability to pressure palsies (HNPP
), a clinically distinct neuropathy. We have identified a severely aff
ected CMT1 patient who is a compound heterozygote for a recessive PMP2
2 point mutation, and a 1.5 Mb deletion in 17p11.2-p12. A son heterozy
gous for the PMP22 point mutation had no signs of neuropathy, while tw
o others heterozygous for the deletion had HNPP, suggesting that point
mutations in PMP22 can result in dominant and recessive alleles contr
ibuting to CMT1A.